Skip to content

The effect of soft tissue artifacts on the kinematics as calculated by multi-segment foot models

The effect of soft tissue artifacts on the kinematics as calculated by multi-segment foot models - Soft Tissue Artifacts on the Foot (STAF)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46288
Enrollment
15
Registered
2018-10-26
Start date
2018-11-29
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

but the results of this study can be applied to all conditions with foot deformities that can lead to gait problems (e.g. cerebral palsy) No specific condition is studied

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subject must be over the age of 18 years and be willing and able to give informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria are: - Wearing insoles or something similar - A right ankle or foot injury in the last 3 months - A history of trauma or surgeries on the right ankle or foot - A hindfoot to lower leg range of motion which is less than: - 40° plantar flexion - 20° dorsal flexion - 10° varus/inversion - 10° valgus/eversion - Pregnancy - Not being able to understand the written informed consent

Design outcomes

Primary

MeasureTime frame
The main study parameters are the 3D movement of the skin-mounted markers with respect to their corresponding bones and the effect of these soft tissue artifacts on the foot kinematics as calculated by several multi-segment foot models.

Secondary

MeasureTime frame
Other study parameters included are age, length, weight, foot posture index, foot length and width, range of motion in the ankle, soft tissue between the bone and skin of the foot.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)